-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
CRISPR Therapeutics AG quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2017 to 2023.
- CRISPR Therapeutics AG Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 84.9M shares, a 7.37% increase year-over-year.
- CRISPR Therapeutics AG annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 79.2M shares, a 1.9% increase from 2022.
- CRISPR Therapeutics AG annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 77.7M shares, a 3.29% decline from 2021.
- CRISPR Therapeutics AG annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 80.4M shares, a 21.9% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)